logo
Plus   Neg
Share
Email

Roche And Spark Therapeutics Agree To Extend Merger Deadline

Roche Holding AG (RHHBY) and Spark Therapeutics (ONCE) agreed to extend the deadline for the Swiss drugmaker's $4.3 billion acquisition of the U.S. biotechnology company.

The companies have agreed to extend deadline for the deal to April 30, 2020, from the previous deadline on January 31, 2020, in order to provide the parties with additional time to satisfy the Regulatory Condition.

In February, Roche Holding AG agreed to acquire Spark Therapeutics for about $4.3 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT
>